Not all sulfonylureas are equal. Glipizide has the lowest hypoglycemia risk, while glyburide is dangerously high-risk - especially for older adults. Learn which drug is safest and what to do if you're on the wrong one.
Read More
Cyclosporine is vital for transplant patients but can damage kidneys if levels aren't tightly monitored. Learn how to track drug levels, recognize early signs of toxicity, and avoid dangerous drug interactions.
Read More
Deprescribing frameworks help safely reduce unnecessary medications in older adults, cutting side effects, falls, and hospitalizations. Evidence shows it’s safe, effective, and urgently needed as polypharmacy rises.
Read More
The 30-month stay under the Hatch-Waxman Act delays generic drug approval when patent lawsuits are filed. Learn how this legal tool affects drug prices, innovation, and patient access to affordable medications.
Read More
Polypharmacy in older adults increases the risk of dangerous drug interactions, falls, and hospitalizations. Learn how deprescribing can safely reduce medication burden and improve health outcomes.
Read More
St. John's Wort can dangerously reduce the effectiveness of warfarin, birth control, antidepressants, and transplant drugs. Learn which medications it interacts with, why it's risky even if you're healthy, and what to do instead.
Read More
Learn the essential questions to ask your doctor about medication side effects to avoid dangerous reactions, reduce ER visits, and take control of your health. Based on FDA, CDC, and clinical guidelines.
Read More
Learn the key differences between medication side effects and true allergic reactions, why mixing them up is dangerous, and how to get tested to avoid unnecessary drug restrictions and healthcare costs.
Read More
The WHO Model List of Essential Medicines sets global standards for affordable, life-saving generics. Used by over 150 countries, it ensures access to proven, cost-effective medicines-especially antibiotics, antivirals, and chronic disease treatments-while promoting quality-assured generics through strict bioequivalence and regulatory requirements.
Read More
Learn how to report adverse drug reactions to the FDA's MedWatch program. Understand what counts as reportable, who can file, and why your report matters for public safety.
Read More